Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.01.13.632776

Exploring the impact of mitonuclear discordance on disease in Latin American admixed populations

Abstract

The coevolution of nuclear and mitochondrial genomes has guaranteed mitochondrial function for millions of years. The introduction of European (EUR) and African (AFR) genomes into the Ameridian continent during the Columbus exchange in Latin America created an opportunity to naturally test different combinations of nuclear and mitochondrial genomes. However, the impact of potential "mitonuclear discordance" (MND, differences in ancestries) has not been evaluated in Latin American admixed individuals (AMR) affected with developmental disorders, even though MND alters mitochondrial function and reduces viability in other organisms. To characterize MND in healthy and affected AMR individuals, we used AMR genotype data from the 1000 Genomes Project (n=385), two cohorts of 22q.11 deletion syndrome patients 22qDS-ARG (n=26) and 22qDS-CHL (n=58), and a cohort of patients with multiple congenital anomalies and/or neurodevelopmental disorders (DECIPHERD, n=172). Based on their importance to mitochondrial function, genes were divided into all mitonuclear genes (n=1035), high-mt (n=167), low-mt (n=793), or OXPHOS (n=169). We calculated local ancestry using FLARE, and estimated MND as the fraction of nuclear mitochondrial genes ancestry not matching the mtDNA ancestry, and {Delta}MND as (MNDoffspring - MNDmother)/MNDmother. Generally, MND showed population and haplogroup distinctive distributions (ANOVA p<0.05), with haplogroup D showing the lowest MND 0.49{+/-}0.17 (mean {+/-} s.d.). MND was significantly lower in 22qDS-ARG patients 0.43{+/-}0.24 and DECIPHERD patients 0.56{+/-}0.12 compared to healthy individuals 0.60{+/-}0.09 (ANOVA p<0.05). OXPHOS and high-mt showed the same trend, but with greater differences between healthy and affected individuals. MND seems to inform population history, and constraint among affected individuals, especially for OXPHOS and high-mt genes. Author summaryWe investigated the role of mitonuclear discordance (MND) in disease among Latin American admixed populations, describing how mismatches between nuclear and mitochondrial ancestries could impact mitochondrial function and disease phenotypes. Utilizing datasets from the 1000 Genomes Project and cohorts with rare genetic disorders, we demonstrated population- and haplogroup-specific patterns of MND, with haplogroup A showing the highest MND values. Affected individuals exhibited significantly lower MND than healthy controls, particularly in genes related to oxidative phosphorylation, suggesting potential links between MND and disease. Intergenerational analyses also revealed constraints on MND, pointing to selective pressures in disease contexts. These findings underscore the importance of mitonuclear interactions in shaping disease phenotypes and highlight the need for further research into their functional and clinical implications, particularly in underrepresented populations.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Ruiz, M., Bohme, D., Repetto, G. M., Rebolledo-Jaramillo, B.. 2025-01-15. Exploring the impact of mitonuclear discordance on disease in Latin American admixed populations. https://doi.org/10.1101/2025.01.13.632776

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Structural variation in repeat elements is widespread in normal human tissues and in tumorigenesis

Somatic mosaicism contributes to genomic variation, yet postzygotic structural variants remain under-characterized. We performed long- and short-read WGS from multiple individuals (n=47 normal tissues; n=168 samples) and identified mosaic structural variants in all individuals and germ layers, impacting a median 285.2 kb/genome. Nearly half of breakpoints were independently validated, with tissue distributions reflecting both early and late developmental origins. Most mosaic variants were repeat-mediated and 8.3% overlapped functional elements, an enrichment compared to germline variants. To extend these analyses in samples where long-read sequencing is infeasible, we measured repeat alterations from short-read sequencing, recapitulating mosaic tissue-specific differences. We characterized tumor- and tissue- specific variation in repeats across 15 cancer types and found tumor-related repeat variation to be similar in scale to that of normal mosaic variation. Tracking repeat changes in cell-free DNA provided a noninvasive approach for tumor monitoring. Our analyses revealed widespread repeat-driven structural variation in health and disease.

genomics↗

RNA isoform-resolved multiplexed sequencing with bioorthogonal barcoding

RNA isoform dysregulation drives disease pathogenesis and is the target of FDA-approved splice-switching therapeutics. However, multiplexed sequencing methods discard splice junction information because only 3' termini are barcoded and counted. Here, we repurpose acylation and click chemistries to conjugate bioorthogonal barcodes (bobcodes) directly onto multiple internal positions along cellular RNAs. Bobcoded RNAs from multiple samples are pooled for multiplexed cDNA synthesis, during which reverse transcriptase switches from each RNA template onto its tethered bobcode with greater than 99% accuracy in species mixing experiments. Bobcode attachment intervals set cDNA insert sizes without a library fragmentation step, and priming with poly(dT) or random hexamers selects between 3'-end counting and full-length isoform capture. A bioorthogonal barcode-sequencing (BOB-seq v0.1) drug screen identifies transcriptome-wide on- and off-target RNA splicing effects and outperforms existing multiplexing RNA sequencing methods in workflow simplicity, sample-to-sample variability, and barcoding accuracy. Bobcodes add isoform resolution to scalable multiplexed RNA sequencing.

genomics↗

Structural polymorphism and population-variable coding capacity of HERV-K(HML-2) in human pangenomes

Approximately 8% of the human genome is derived from ancient retroviral infections. The most recently integrated of these endogenous retroviruses is the HERV-K(HML-2) clade, whose expression has been associated with cancer, amyotrophic lateral sclerosis, and embryogenesis. Studies of HERV expression, particularly HML-2, have relied predominantly on short-read sequencing. However, the high similarity among HML-2 proviruses prevents many short reads from being assigned uniquely to individual loci. We therefore compared haplotype-resolved long-read genome assemblies from 292 donors to resolve variation in proviral structure and coding capacity. Several loci previously thought to be fixed were structurally polymorphic. Tandem arrays occurred at 13 loci and contained up to six proviral copies in a single array. At 8q11.23, we identified a previously undescribed full-length provirus in one haplotype. All 583 other haplotypes carried a solo-LTR. We found that standard reference genomes failed to represent the coding capacity retained in many individuals, whose proviruses contained intact open reading frames despite disruptive mutations in the reference sequences. Short-read genotypes left 32.5% of the tested donor-variant pairs unresolved at sites associated with viral reading frames. These findings show why HML-2 expression must be interpreted in the context of the structural and coding alleles each individual carries.

genomics↗